Action 002022 SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shanghai Kehua Bio-Engineering Co.,Ltd

Actions

002022

CNE000001KC9

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 02/07/2024 		Varia. 5j. Varia. 1 janv.
5,73 CNY +0,70% Graphique intraday de Shanghai Kehua Bio-Engineering Co.,Ltd +1,78% -49,65%
13/06 Le kit de facteur de croissance de Kehua Bio-Engineering obtient un certificat d'enregistrement MT
28/04 Shanghai Kehua Bio-Engineering Co, Ltd présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Kehua Bio-Engineering's Growth Factor Kit Gets Registration Certificate
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Kehua Bio-Engineering Gets Registration Certificates for Two Devices
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) agreed to acquire 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd. for CNY 514.3 million.
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit
Shanghai Kehua Bio-Engineering Co.,Ltd(XSEC:002022) added to S&P Global BMI Index
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments
Kehua Bio-Engineering Registers Diagnostic Reagent
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002022
  4. Actualités Shanghai Kehua Bio-Engineering Co.,Ltd
  5. Autres langues